In summary, the feasibility of the proposed strategy that targeting and intervening the mutual PLK1 on both CAFs and the inner CCA tumor cells by targeting AA-HA-ODA sequentially was verified, which might provide enlightenment for clinical cholangiocarcinoma treatment. This evidence concerns the gene PLK1 and cholangiocarcinoma.